Skip to main content

Masimo Corp(MASI-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low175.46
Day High175.57
Open:175.57
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Masimo Corp

Select a category then submit the form to load news
Masimo (MASI) was downgraded to a Hold Rating at Wells Fargo
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Masimo (MASI), Janux Therapeutics Inc (JANX) and Beta Bionics, Inc. (BBNX)
Analysts Conflicted on These Healthcare Names: Danaher (DHR), Cogent Biosciences (COGT) and Masimo (MASI)
Analysts Conflicted on These Healthcare Names: Masimo (MASI) and Medtronic (MDT)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Masimo (MASI) and Medtronic (MDT)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT) and Masimo (MASI)
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and Masimo (MASI)
Analysts Offer Insights on Healthcare Companies: Masimo (MASI) and Medtronic (MDT)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Masimo (MASI) and Medtronic (MDT)
Masimo to Be Acquired by Danaher in Merger
Analysts Conflicted on These Healthcare Names: Masimo (MASI) and Hims & Hers Health (HIMS)
Analysts Are Bullish on Top Healthcare Stocks: IDEAYA Biosciences (IDYA), Masimo (MASI)
Masimo (MASI) Receives a Buy from Wells Fargo
Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS), Masimo (MASI) and REPRO-MED Systems (KRMD)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), GeneDx Holdings (WGS) and Masimo (MASI)
Masimo Issues Strong Preliminary Results for 2025 Performance
Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch

Profile

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.